Skip to main content

Want a detailed portfolio tracker?

BridgeBio Oncology Therapeutics Inc Com (BBOT) P/E (2025 - 2026)

BridgeBio Oncology Therapeutics Inc Com (BBOT) P/E from Sep 30, 2025 to Jul 21, 2026. The TTM BridgeBio Oncology Therapeutics Inc Com (BBOT) P/E is -5.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BridgeBio Oncology Therapeutics Inc Com (BBOT)

YearP/EChange
2026-5.53-53.59%
2025-11.92N/A

Comparison BridgeBio Oncology Therapeutics Inc Com (BBOT) P/E with competitors

BridgeBio Oncology Therapeutics Inc Com (BBOT) P/E is -5.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.35%
FGENFibroGen Inc0.24-104.34%
CHRSCoherus Biosciences Inc0.85-115.34%
FBIOFortress Biotech Inc0.95-117.15%
ORMPOramed Pharmaceuticals Inc1.50-127.16%
AGENAgenus Inc3.01-154.39%
INVAInnoviva Inc3.15-157.00%
VXRTVaxart Inc3.55-164.15%
CRMDCorMedix Inc3.63-165.58%
CVACCureVac N.V.4.45-180.35%
GLPGGalapagos NV4.86-187.81%
SRPTSarepta Therapeutics Inc4.88-188.23%
ABEOAbeona Therapeutics Inc5.39-197.37%
ABUSArbutus Biopharma Corp5.60-201.13%
ZVRAZevra Therapeutics Inc5.89-206.40%
SPROSpero Therapeutics Inc6.23-212.57%
CGENCompugen Ltd6.31-214.11%
RIGLRigel Pharmaceuticals6.87-224.20%
SLXNSilexion Therapeutics Corp7.30-231.86%
OMEROmeros Corporation9.26-267.33%
AUPHAurinia Pharmaceuticals Inc9.58-273.23%
PLXProtalix BioTherapeutics Inc10.89-296.83%
ACADAcadia Pharmaceuticals Inc11.73-311.97%
TBPHTheravance Biopharma Inc12.26-321.61%
ADMAAdma Biologics Inc12.42-324.43%
HRMYHarmony Biosciences Holdings Inc13.82-349.77%
SABSSAB Biotherapeutics Inc14.14-355.48%
NAGENiagen Bioscience Inc14.82-367.81%
INCYIncyte Corp15.82-385.96%
REGNRegeneron Pharmaceuticals Inc15.86-386.58%
PBYIPuma Biotechnology Inc17.32-412.95%
CPRXCatalyst Pharmaceuticals Inc17.44-415.18%
EXELExelixis Inc17.54-416.96%
TGTXTG Therapeutics Inc18.97-442.77%
MDXGMimedx Group Inc20.55-471.44%
XOMAXOMA Royalty Corp22.87-513.42%
ARGXArgen X SE24.30-539.15%
CTMXCytomX Therapeutics Inc24.82-548.60%
XOMAOXOMA Royalty Corp25.34-558.07%
HALOHalozyme Therapeutics Inc25.62-563.11%
XOMAPXOMA Royalty Corp25.67-563.95%
VRTXVertex Pharmaceuticals Inc27.99-605.96%
RPRXRoyalty Pharma plc - Class A28.69-618.48%
SLNOSoleno Therapeutics Inc29.02-624.41%
ASNDAscendis Pharma A/S30.09-643.75%
LGNDLigand Pharmaceuticals Inc - Class B37.91-785.20%
APLSApellis Pharmaceuticals Inc39.02-805.25%
BMRNBiomarin Pharmaceutical Inc42.21-862.91%
KRYSKrystal Biotech Inc45.34-919.51%
ONCBeiGene Ltd69.54-1356.83%
PHARPharming Group N.V.75.03-1455.97%
TECHBio-Techne Corp101.96-1942.74%
VCELVericel Corp109.92-2086.66%
ALNYAlnylam Pharmaceuticals Inc117.96-2232.03%
GMABGenmab140.29-2635.54%
TLXTelix Pharmaceuticals Ltd162.15-3030.66%
CORTCorcept Therapeutics Inc212.86-3947.07%